Näreoja Tuomas, Vehniäinen Markus, Lamminmäki Urpo, Hänninen Pekka E, Härmä Harri
Laboratory of Biophysics, Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Tykistökatu 6A, 20520 Turku, Finland.
J Immunol Methods. 2009 Jun 30;345(1-2):80-9. doi: 10.1016/j.jim.2009.04.008. Epub 2009 Apr 18.
Nanoparticle labels have been shown to improve the sensitivity of a sandwich immunoassay significantly. Further improvement in sensitivity is limited by nonspecific binding of the nanoparticle labels. Here, an experimental characterization of assay performance was carried out using clinically important analytes thyroid stimulating hormone and prostate-specific antigen. Particular attention was paid to characterization of nonspecific binding properties of nanoparticle labels. Therefore, different particle sizes and high affinity monoclonal antibodies (Mab) and their Fab and scFv recombinant antibody fragments were investigated. Combination of Fab fragment as a capture antibody and Mab as a detector antibody on a nanoparticle label resulted in high signal-to-background ratio consistently. Against the expectations no significant difference in nonspecific binding was found using fragmented antibodies compared to Mabs. The results also suggested that nonspecific binding was independent of the particle size. The particle size had a significant effect on the specific signal favouring the use of small particles giving a high specific signal. This study indicated that nonspecific binding is not readily affected by the physical size of the nanoparticle label or antibodies used in the assay.
纳米颗粒标记物已被证明能显著提高夹心免疫测定的灵敏度。灵敏度的进一步提高受到纳米颗粒标记物非特异性结合的限制。在此,使用临床重要分析物促甲状腺激素和前列腺特异性抗原对测定性能进行了实验表征。特别关注了纳米颗粒标记物非特异性结合特性的表征。因此,研究了不同粒径以及高亲和力单克隆抗体(Mab)及其Fab和scFv重组抗体片段。在纳米颗粒标记物上,将Fab片段作为捕获抗体与Mab作为检测抗体相结合,始终能产生高信噪比。与预期相反,与单克隆抗体相比,使用片段化抗体时未发现非特异性结合有显著差异。结果还表明,非特异性结合与粒径无关。粒径对特异性信号有显著影响,倾向于使用能产生高特异性信号的小颗粒。这项研究表明,非特异性结合不易受到测定中使用的纳米颗粒标记物或抗体的物理尺寸的影响。